Pharmaceutical Intermediates Market Status And Ongoing Development Trends Reviewed In New Report
Active pharmaceutical ingredient is a substance that is intended to supply pharmacological activity or other direct effect in diagnosis, cure, mitigation, treatment, or prevention of disease. Pharmaceutical intermediates are chemical compounds that are building blocks used in production of active pharmaceutical ingredients.
Major factor driving growth of the global market is increasing production of active pharmaceutical ingredients in medicine preparation. In addition, changing lifestyle pattern, rising prevalence of various chronic disease, and increasing geriatric population with various diseases are some other factors expected to support growth of the pharmaceutical intermediates market to certain extent.
However, stringent government regulations related to product approval is a major factor expected to hamper growth of the global market.
The product type segment in the global target market is segmented on the basis of GMP and non-GMP. The GMP segment is expected to contribute significant revenue share in the global market.
The application segment in the global target market is segmented on the basis of antibiotics, antipyretic analgesics, and vitamins. The antibiotics segment is expected to contribute significant revenue share in the global market.
The distribution channel segment in the global target market is segmented on the basis of direct sales and distributor. The distributor segment is expected to contribute significant revenue share in the global market.
On the basis of region, the global target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Get Free Sample Copy Of This Research @ https://marketresearch.biz/report/pharmaceutical-intermediates-market/request-sample/
North America is expected to dominate the global market and is expected to continue its dominance over the forecast period. This can be attributed to growing merger and acquisition activities and increasing investment for R&D activates and novel product offerings by major players operating in the economies in this region. The markets in Latin America and Middle East & Africa are expected to witness moderate growth over the forecast period.
Key players operating in the target market include Aceto Corporation, Easter Chemical Corporation, BASF SE, Midas Pharma GmbH, A.R. Life Sciences Private Limited, Lianhe Chemical Technology Co Ltd., Dishman Pharmaceuticals and Chemicals Limited, Codexis, Inc., Sanofi Winthrop Industrie S.A., Vertellus Holdings LLC, Dextra Laboratories Limited, Chemcon Specialty Chemical Pvt. Ltd., and ZCL Chemical Ltd.